MWNA
MED icon

Marshall Wace North America’s Medifast MED Stock Holding History

Marshall Wace North America’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,556
Closed -$326K – 1415
2019
Q1 		$326K Buy
2,556
+177
+7% +$22.4K ﹤0.01% 886
2018
Q4 		$297K Buy
+2,379
New +$407K ﹤0.01% 889
2018
Q3 		– Sell
-100,057
Closed -$16M – 1187
2018
Q2 		$16M Sell
100,057
-120,668
-55% -$15.4M 0.09% 245
2018
Q1 		$20.6M Buy
220,725
+118,477
+116% +$8.85M 0.1% 230
2017
Q4 		$7.14M Sell
102,248
-4,765
-4% -$316K 0.04% 474
2017
Q3 		$6.31M Buy
107,013
+3,201
+3% +$159K 0.04% 482
2017
Q2 		$4.26M Buy
103,812
+81,075
+357% +$3.52M 0.03% 542
2017
Q1 		$1M Buy
+22,737
New +$979K 0.01% 700

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Marshall Wace North America's MED Position: Q2 2019 in Review

Marshall Wace North America sold out of Medifast (MED) in Q2 2019, closing a stake of 2,556 shares — an estimated $326K sold.

Marshall Wace North America first reported a position in MED in Q1 2017 and held it in 8 quarters. The position peaked at $20.6M in Q1 2018. 251 funds tracked by Wall St. Rank hold MED as of Q2 2019.

  • Marshall Wace North America reported no remaining Medifast position as of Q2 2019 after selling out during the quarter.
  • Marshall Wace North America sold 2,556 Medifast shares in Q2 2019, an estimated $326K.
  • Marshall Wace North America first reported a position in Medifast in Q1 2017 and held it in 8 quarters.
  • Marshall Wace North America's Medifast position peaked at $20.6M in Q1 2018.
  • 251 funds tracked by Wall St. Rank held Medifast as of Q2 2019.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.